Advertisement
Organisation › Details
Yposkesi (FR)
Yposkesi, an SK pharmteco company, is one of the largest Contract Development and Manufacturing Organization’s (CDMO) in Europe. Dedicated to viral vector manufacturing for gene therapy, Yposkesi is a one-stop shop offering a full range of services for lentiviral vectors & AAV (Adeno-Associated Virus) manufacturing: feasibility study, bioprocess development (upstream/downstream & fill and finish), analytical development, small/pilot to large-scale production, cGMP manufacturing of clinical batches, quality control & assurance and regulatory support. With a current 50,000ft2 (approx. 5,000m2) footprint, Yposkesi’s facility operates multiple manufacturing suites for bulk drug substances (up to 1,000L) and Fill & Finish. By 2023, the company will increase its global footprint to 100.000ft2 (approx. 10,000m2) with a second large-scale facility designed for EMA and FDA compliance. Yposkesi sustainably invests in bioprocessing innovation in order to deliver high quality gene-modified cell therapies and in vivo gene therapy projects. Yposkesi employs around 200 people and is located on the Genopole Campus in Corbeil-Essonnes (South of Paris), France. *
Start | 2016-11-01 established | |
Predecessor | Généthon (FR) | |
Industry | contract manufacturing (biologicals) | |
Industry 2 | viral vector_o | |
Person | Lamproye, Alain (Yoskesi 201807 CEO before Novasep 201511 President of Biopharma Business Unit) | |
Region | Paris | |
Country | France | |
Street | 26 rue Henri Auguste-Desbruères Génopôle | |
City | 91100 Corbeil-Essonnes | |
Tel | +33-1-6161-7001 | |
Address record changed: 2022-03-08 | ||
Basic data | Employees | D: 101 to 500 (2022-02-28) |
* Document for »About Section«: Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for SK Group (Group)
- [1] Yposkesi. (2/28/22). "Press Release: Yposkesi, an SK pharmteco Company, Appoints US-based Executive Director for Business Development". Corbeil-Essonnes....
- [2] Arvelle Therapeutics GmbH. (5/26/20). "Press Release: Arvelle Announces Closing of Final Tranche of Series A Financing Round". Zug....
- [3] Yposkesi. (2/24/20). "Press Release: Yposkesi Welcomes Patrick Lansky as VP of US Sales & Marketing". Corbeil-Essonnes....
- [4] Yposkesi. (6/5/19). "Press Release: Servier Appoints Yposkesi for Lentiviral Vector GMP-Manufacturing in CAR-T Cell Development Technology". Suresnes & Corbeil-Essonnes....
- [5] Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel....
- [6] Yposkesi. (7/9/18). "Press Release: Yposkesi Appoints Dr. Fraser Wright as Senior Advisor". Corbeil-Essonnes....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top